Latest Headlines
-
PathAI Expands AISight® Digital Pathology Adoption With Four New Laboratory Partners
3/24/2025
PathAI, a global leader in AI-powered pathology, is pleased to announce that Annapath Pathology Services, Inc., Peninsula Pathology Medical Group (PPMG), Pathology Group of Louisiana (PGL), and SigmaCore have adopted the AISight® Image Management System (IMS) to enhance their digital pathology operations.
-
Techcyte Unveils Fusion, The First Unified Anatomic And Clinical Digital Pathology Platform
3/24/2025
Techcyte, a leader in AI-powered digital pathology, announced the launch of Fusion, the first open, standards-based, SaaS platform designed to unify anatomic and clinical pathology workflows.
-
Amerigo Scientific Announces Ultra-Sensitive CLIA Kits Offering Reliable Detection Results For Multiple Trace Substances
3/22/2025
Amerigo Scientific is a distributor focused on providing critical products and services to biomedical and life science communities. Recently, the company released its ultra-sensitive chemiluminescence immunoassay (CLIA) kits developed to detect multiple low abundance analytes in various samples, providing researchers and laboratories with critical insights to improve experiment outcomes.
-
A New Standard In Clinical Care For MASH Patients: HistoIndex Launches FibroSIGHT™
3/21/2025
HistoIndex, a global leader in stain-free digital pathology solutions for managing fibrotic diseases, has announced the launch of their first Laboratory Developed Test (LDT) FibroSIGHT™ – now available in the United States.
-
Grifols And Inpeco Joining Forces To Deliver Transfusion Medicine 'Lab Of The Future'
3/20/2025
Grifols a global healthcare company and leading manufacturer of plasma-derived medicines and innovative diagnostic solutions, today announced it has signed a strategic agreement with Inpeco, a global leader in total laboratory automation technologies, to provide transfusion medicine labs with complete, tailored instrumentation, robotics and software capabilities to modernize their operations and make them more efficient.
-
Revvity Expands Alliance With Genomics England To Drive Research Into Newborn Genomic Sequencing In England
3/20/2025
Revvity, Inc. today announced an agreement with Genomics England to further collaborate on the Generation Study. Under the new contract, Revvity will now also provide DNA sequencing services to help screen newborns for rare genetic conditions.
-
TMRW Life Sciences Announces Launch Of Its Latest Offering In Frozen IVF Specimen Management And Storage: TMRW Vault™
3/19/2025
TMRW Life Sciences (TMRW), the fertility technology company transforming the storage and management of frozen eggs, embryos, and sperm, announced the upcoming launch of its latest offering: TMRW Vault—a state-of-the-art liquid nitrogen smart tank and digital workstation.
-
Northwestern Medicine And Vitestro Collaborate To Advance Autonomous Robotic Phlebotomy
3/19/2025
Northwestern Medicine, Chicago's premier integrated academic health system, and Vitestro, a pioneer in autonomous robotic vascular access and diagnostic blood collection, today announced a multi-year collaboration to advance automation in phlebotomy and transform the patient experience.
-
HealthTrackRx Develops Next-Morning PCR Test For Measles Amid Rising U.S. Cases
3/18/2025
In response to the alarming rise in measles cases across New Mexico and Texas, HealthTrackRx, the nation's premier provider of molecular diagnostic testing, today announced the development of a next-morning PCR test for measles.
-
HIV And Syphilis Testing Just Got Faster: bioLytical Launches The 1-Minute INSTI® Multiplex HIV-1/2 Syphilis Antibody Test In Australia
3/18/2025
bioLytical Laboratories Inc. (“bioLytical”), a global leader in rapid infectious disease diagnostics, announces the launch of its INSTI® Multiplex HIV-1/2 Syphilis Antibody Test in Australia.